In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Priyadarshini D. and co-author, Sabyasachi Kar, analyze the viability of CBDCs from the perspective of the rapid digitalization taking place in India, and suggest a few steps forward.
On April 18 we hosted Mohan Kumar, Jahnavi Phalkey, and Rajan Anandan for a discussion on Anirudh Suri's book The Great Tech Game: Shaping Geopolitics and the Destinies of Nations. The discussion was moderated by Rudra Chaudhuri.
There may be merit in first creating the law, then addressing other concerns later.
On April 8, we hosted BV Naidu, Anku Jain, Sana Hashmi, and Stanley Wang for a roundtable discussion on Taiwanese investments in India.
Priyadarshini D. discussed India's rollout of CBDCs and the country's transition towards a more efficient, inclusive, and sustainable digital economy.